The pharmaceutical cannabis producer is preparing for a big announcement…
The post The Creso Pharma (ASX:CPH) share price is frozen today. Here’s why appeared first on The Motley Fool Australia. –
The Creso Pharma Ltd (ASX: CPH) share price isn’t going anywhere on Thursday. This comes after the cannabis and psychedelics company requested a trading halt in the minutes during market open.
As such, Creso Pharma shares are frozen at 13 cents apiece. It’s worth noting the company’s shares have gained 13% in the past week.
Why are Creso Pharma shares in a trading halt?
Creso Pharma shares were placed in a trading halt this morning pending an important announcement from the company.
In a statement to the ASX, Creso Pharma said the announcement is regarding the receipt of a material licence from Health Canada.
While no further details have been given, Creso Pharma’s wholly-owned subsidiary, Mernova, was yesterday granted a licence extension to sell medicinal cannabis in Canada.
The news sent the Creso Pharma share price as high as 14 cents, however some profit taking occurred. Its shares ended the day 4% higher at 13 cents.
The green light allows Mernova to expand its sales base by entering the medicinal cannabis market in Canada. In May 2020, the company had received a recreational market licence from Health Canada.
Under the new licence, Mernova can sell its products directly to consumers who are licenced to obtain cannabis for medical purposes. In the past, Health Canada had only allowed the company to sell its medicinal products through wholesalers.
The shares will remain in pre-open until an official announcement is made or the start of trade on Monday 16 August, the company said.
Creso Pharma share price summary
Since this time last year, the Creso Pharma share price has risen sharply by more than 200%. However, in 2021, the company’s shares paint a different picture for investors, down almost 30%.
Creso Pharma has a market capitalisation of roughly $155.5 million with approximately 1.2 billion shares on its registry.
Should you invest $1,000 in Creso Pharma right now?
Before you consider Creso Pharma, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Creso Pharma wasn’t one of them.
The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of May 24th 2021
Here’s why the Creso Pharma (ASX:CPH) share price is up 8% today
Here’s why the Creso Pharma (ASX:CPH) share price is up 7%
Why the Creso Pharma (ASX:CPH) share price is soaring 9% higher today
Here’s why the Creso Pharma (ASX:CPH) share price is surging 15% higher
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.